NCT06855277
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06855277
Title Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC (AcTFirst)
Acronym AcTFirst
Recruitment Recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR | AUS

Facility Status City State Zip Country Details
Sansum Clinic RECRUITING Santa Barbara California 93105 United States Details
Rocky Mountain Cancer Centers RECRUITING Denver Colorado 80218 United States Details
University of Kansas Hospital RECRUITING Kansas City Kansas 66160 United States Details
Wash U School of Medicine RECRUITING St Louis Missouri 63110 United States Details
Carolina Urologic Research Center RECRUITING Myrtle Beach South Carolina 29572 United States Details
Urology San Antonio RECRUITING San Antonio Texas 78229 United States Details
Novartis Investigative Site RECRUITING Darlinghurst New South Wales 2010 Australia Details
Novartis Investigative Site RECRUITING Adelaide South Australia 5000 Australia Details
Novartis Investigative Site RECRUITING Guangzhou Guangdong 510632 China Details
Novartis Investigative Site RECRUITING Wuhan Hubei 430022 China Details
Novartis Investigative Site RECRUITING Wuhan Hubei 430030 China Details
Novartis Investigative Site RECRUITING Nanjing Jiangsu 210006 China Details
Novartis Investigative Site RECRUITING Nanjing Jiangsu 210029 China Details
Novartis Investigative Site RECRUITING Shenyang Liaoning 110011 China Details
Novartis Investigative Site RECRUITING Chengdu Sichuan 610041 China Details
Novartis Investigative Site RECRUITING Hangzhou Zhejiang 310022 China Details
Novartis Investigative Site RECRUITING Beijing 100034 China Details
Novartis Investigative Site RECRUITING Guangzhou 510060 China Details
Novartis Investigative Site RECRUITING Shanghai 200025 China Details
Novartis Investigative Site RECRUITING Shanghai 200032 China Details
Novartis Investigative Site RECRUITING Shanghai 200127 China Details
Novartis Investigative Site RECRUITING Hong Kong 999077 Hong Kong Details
Novartis Investigative Site RECRUITING Mumbai Maharashtra 400 012 India Details
Novartis Investigative Site RECRUITING Sapporo Hokkaido 060 8648 Japan Details
Novartis Investigative Site RECRUITING Kobe Hyōgo 6500047 Japan Details
Novartis Investigative Site RECRUITING Yokohama Kanagawa-ku 236-0004 Japan Details
Novartis Investigative Site RECRUITING Chiba 260-8717 Japan Details
Novartis Investigative Site RECRUITING Fukuoka 811-0213 Japan Details
Novartis Investigative Site RECRUITING Fukuoka 812-0033 Japan Details
Novartis Investigative Site RECRUITING Kyoto 606 8507 Japan Details
Novartis Investigative Site RECRUITING Singapore 119074 Singapore Details
Novartis Investigative Site RECRUITING Singapore 168583 Singapore Details
Novartis Investigative Site RECRUITING Singapore 169608 Singapore Details
Novartis Investigative Site RECRUITING Seoul Korea 03080 South Korea Details
Novartis Investigative Site RECRUITING Kaohsiung City 83301 Taiwan Details
Novartis Investigative Site RECRUITING Taoyuan District 33305 Taiwan Details
Novartis Investigative Site RECRUITING Sutton Surrey SM2 5PT United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field